Corbevax gets nod from DGCI as heterologous Covid-19 booster

Corbevax gets nod from DGCI as heterologous Covid-19 booster

Biological E’s corbevax has become the first vaccine in India to get regulatory approval for a heterologous Covid-19 booster shot. People who are 18 years and above and have already taken two doses of either Covishield or Covaxin can now receive a dose of Corbevax as a heterologous Covid-19 booster. Hyderabad-based pharmaceutical and vaccines company … Read more

Biological E reduces Corbevax Covid-19 vaccine price to Rs 250 per dose

Biological E reduces Corbevax Covid-19 vaccine price to Rs 250 per dose

Biological E, a Hyderabad-based vaccine maker, on Monday announced a reduction in the price of the Corbevax Covid-19 vaccine to Rs 250 a dose. Corbevax was earlier priced at Rs 840 per dose. The new price of Rs 250 per dose, inclusive of GST, will be charged for the vaccine at private Covid-19 vaccination centres. … Read more

Coronavirus Vaccine For Kids: DCGI grants EUA to Covaxin for 6 to 12 year age group and Corbevax for 5 to 12 Years Age Group

Coronavirus Vaccine For Kids: DCGI grants EUA to Covaxin for 6 to 12 year age group and Corbevax for 5 to 12 Years Age Group

DCGI Approved Corbevax Vaccine for 5 to 12 Years Age Group, Covaxin Vaccine for 6-12 Age Groups: The Drugs Controller General of India (DCGI) has granted restricted emergency use authorisation (EUA) to Covaxin for use in 6 to 12 years old children. The national drug regulator has asked Covaxin manufacturer Bharat Biotech to submit safety data. … Read more

Biological E to get mRNA technology from WHO to produce Covid-19 vaccines

Biological E to get mRNA technology from WHO to produce Covid-19 vaccines

City-based vaccine maker Biological E. Limited on Monday said the company was selected as a recipient of mRNA technology to produce COVID-19 vaccines from the World Health Organisation. A press release from BE Limited said the WHO’s Advisory Committee on Vaccine Product Development (ACPDV) selected the firm after examining a number of proposals from India, … Read more

Over 3 lakh doses of Covid vaccine given to children aged 12-14 years on day 1

Over 3 lakh doses of Covid vaccine given to children aged 12-14 years on day 1

The vaccination against COVID-19 in the age group of 12-14 years started on Wednesday with Biological E’s intramuscular vaccine Corbevax, two doses of which are to be administered 28 days apart. Over 3 lakh children between 12 and 14 years have received their first shot of Covid vaccine taking the total doses administered in the … Read more

Vaccination drive: Over 23,000 children aged 12-14 years received first dose of Corbevax vaccine

Vaccination drive: Over 23,000 children aged 12-14 years received first dose of Corbevax vaccine

According to CoWIN, vaccination for this age group picked up pace around 3 pm on Wednesday and 23,457 children aged 12-14 years have received vaccine doses till 9 pm. Over 23,000 children aged 12 to 14 years received their first dose of the Corbevax vaccine on the first day of the vaccination drive for this … Read more

Covid vaccination of children in 12-14 age group begins tomorrow

Covid vaccination of children in 12-14 age group begins tomorrow

The decision to start vaccination for the 12-14 age group was taken after due deliberations with scientific bodies, the health ministry said. The government on Monday said Covid-19 vaccination of children in the age group of 12-14 years will begin from Wednesday. All those born in 2008, 2009 and 2010 will be administered the Corbevax … Read more

Biological E to make 100 m doses of Corbevax per month

covid vaccine 2 1

The company said it has reached production levels of 75 million doses per month at present and would make 100 plus million doses per month from February 2022.  Hyderabad-based Biological E said on Tuesday that it would deliver the 300 million doses of the Covid-19 vaccine, Corbevax, as promised to the government of India. Corbevax … Read more

Covid-19 vaccination milestone: Entire world looking up to India after our success, says PM Modi

1 447

The PM exhorted that the country needs to institutionalise the best practices learnt during the last one and a half years. PM Modi interacted with the domestic vaccine manufacturers at Lok Kalyan Marg. Prime Minister Narendra Modi on Saturday praised efforts of Indian vaccine manufacturers, which, he said, resulted in the country crossing the milestone … Read more

Covid-19 vaccine: Biological E gets DCGI nod for Phase 2/3 trials on kids, adults

covid 19 vaccine for children

“The approvals from the DCGI will encourage us to move forward and produce the Covid-19 vaccine to meet the country’s vaccination needs. These approvals will help support subsequent filings with the World Health Organisation as well,” Bio E MD Mahima Datla. Biological E has received approval from the Drugs Controller General of India (DCGI) to … Read more